Influence of E-cadherin expression on the mammographic appearance of invasive nonlobular breast carcinoma detected at screening

Radiology

Volumn 253, Issue 1, 2009, Pages 51-55

  Doyle, Sarah ^a   Evans, Andrew J ^a   Rakha, Emad A ^a   Green, Andrew R ^a   Ellis, Ian O ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

UVOMORULIN; CADHERIN;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CANCER SCREENING; CANCER SIZE; CONTROLLED STUDY; DIAGNOSTIC IMAGING; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INVASIVE CARCINOMA; MAJOR CLINICAL STUDY; MAMMOGRAPHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; BREAST TUMOR; CALCINOSIS; CANCER DIAGNOSIS; CANCER INVASION; CANCER STAGING; CASE CONTROL STUDY; CHI SQUARE DISTRIBUTION; METABOLISM; MIDDLE AGED; PAGET NIPPLE DISEASE; PATHOLOGY; RADIOGRAPHY;

AGED; BREAST NEOPLASMS; CADHERINS; CALCINOSIS; CARCINOMA, DUCTAL, BREAST; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MAMMOGRAPHY; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING;

EID: 70350475759     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.2531090045     Document Type: Article

References (31)

1. Moll R, Mitze M, Frixen UH, Birchmeier W. Differential loss of E-cadherin expression in infiltrating ductal and lobular carcinomas. Am J Pathol 1993;143(6):1731-1742.
2. de Leeuw WJ, Berx G, Vos CB, et al. Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ. J Pathol 1997;183(4): 404-411.
3. Bane AL, Tjan S, Parkes RK, Andrulis I, O'Malley FP. Invasive lobular carcinoma: to grade or not to grade. Mod Pathol 2005; 18(5):621-628.
4. Rakha EA, Abd El Rehim D, Pinder SE, Lewis SA, Ellis IO. E-cadherin expression in invasive non-lobular carcinoma of the breast and its prognostic significance. Histopathology 2005;46(6):685-693.
5. Mahler-Araujo B, Savage K, Parry S, Reis-Filho JS. Reduction of E-cadherin expression is associated with non-lobular breast carcinomas of basal-like and triple negative phenotype. J Clin Pathol 2008;61(5):615-620.
6. Gill HK, Berg WA. Case 39: invasive lobular carcinoma. Radiology 2001;221(1):132-136.
7. Vleminckx K, Kemler R. Cadherins and tissue formation: integrating adhesion and signaling. Bioessays 1999;21(3):211-220.
8. Mareel M, Vleminckx K, Vermeulen S, Bracke M, Van Roy F. E-cadherin expression: a counterbalance for cancer cell invasion. Bull Cancer 1992;79(4):347-355.
9. Oka H, Shiozaki H, Kobayashi K, et al. Expression of E-cadherin cell adhesion molecules in human breast cancer tissues and its relationship to metastasis. Cancer Res 1993; 53(7):1696-1701.
10. Berx G, Cleton-Jansen AM, Nollet F, et al. E-cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers. EMBO J 1995;14(24):6107-6115.
11. Siitonen SM, Kononen JT, Helin HJ, Rantala IS, Holli KA, Isola JJ. Reduced E-cadherin expression is associated with invasiveness and unfavorable prognosis in breast cancer. Am J Clin Pathol 1996;105(4):394-402.
12. Cornford EJ, Wilson AR, Athanassiou E, et al. Mammographic features of invasive lobular and invasive ductal carcinoma of the breast: a comparative analysis. Br J Radiol 1995;68(809):450-453.
13. Mendelson EB, Harris KM, Doshi N, Tobon H. Infiltrating lobular carcinoma: mammographic patterns with pathologic correlation. AJR Am J Roentgenol 1989;153(2):265-271.
14. Hilleren DJ, Andersson IT, Lindholm K, Linnell FS. Invasive lobular carcinoma: mammographic findings in a 10-year experience. Radiology 1991;178(1):149-154.
15. Newstead GM, Baute PB, Toth HK. Invasive lobular and ductal carcinoma: mammographic findings and stage at diagnosis. Radiology 1992;184(3):623-627. [Published correction appears in Radiology 1992;185(2): 616.]
16. Helvie MA, Paramagul C, Oberman HA, Adler DD. Invasive lobular carcinoma: imaging features and clinical detection. Invest Radiol 1993;28(3):202-207.
17. Arpino G, Bardou VJ, Clark GM, Elledge RM. Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome. Breast Cancer Res 2004;6(3): R149-R156.
18. Rakha EA, El-Sayed ME, Powe DG, et al. Invasive lobular carcinoma of the breast: response to hormonal therapy and outcomes. Eur J Cancer 2008;44(1):73-83.
19. Le GalM,Ollivier L, Asselain B, et al. Mammographic features of 455 invasive lobular carcinomas. Radiology 1992;185(3):705-708.
20. Krecke KN, Gisvold JJ. Invasive lobular carcinoma of the breast: mammographic findings and extent of disease at diagnosis in 184 patients. AJR Am J Roentgenol 1993;161(5): 957-960.
21. Caramella T, Chapellier C, Ettore F, Raoust I, Chamorey E, Balu-Maestro C. Value of MRI in the surgical planning of invasive lobular breast carcinoma: a prospective and a retrospective study of 57 cases - comparison with physical examination, conventional imaging, and histology. Clin Imaging 2007; 31(3):155-161.
22. Quan ML, Sclafani L, Heerdt AS, Fey JV, Morris EA, Borgen PI. Magnetic resonance imaging detects unsuspected disease in patients with invasive lobular cancer. Ann Surg Oncol 2003;10(9):1048-1053.
23. Mann RM, Hoogeveen YL, Blickman JG, Boetes C. MRI compared to conventional diagnostic work-up in the detection and evaluation of invasive lobular carcinoma of the breast: a review of existing literature. Breast Cancer Res Treat 2008;107(1):1-14.
24. Holland R, Mravunac M, Hendriks JH, Bekker BV. So-called interval cancers of the breast: pathologic and radiologic analysis of sixty-four cases. Cancer 1982;49(12):2527-2533.
25. Ciatto S, Rosselli del Turco M, Bonardi R, Bianchi S. Mammographic screening. An analysis of the characteristics of interval carcinomas observed in the program in the province of Firenze (1989-1991) [in Italian]. Radiol Med 1994;87(4):412-416.
26. Daly CA, Apthorp L, Field S. Second round cancers: how many were visible on the first round of the UK National Breast Screening Programme, 3 years earlier? Clin Radiol 1998;53(1):25-28.
27. De Nunzio MC, Evans AJ, Pinder SE, et al. Correlations between the mammographic features of screen detected breast cancer and pathologic prognostic factors. Breast 1997;6(3):146-149.
28. Healey EA, Osteen RT, Schnitt SJ, et al. Can the clinical and mammographic findings at presentation predict the presence of an extensive intraductal component in early stage breast cancer? Int J Radiat Oncol Biol Phys 1989;17(6):1217-1221.
29. Stomper PC, Connolly JL. Ductal carcinoma in situ of the breast: correlation between mammographic calcification and tumor subtype. AJR Am J Roentgenol 1992;159(3): 483-485.
30. McCormack VA, dos Santos Silva I. Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2006; 15(6):1159-1169.
31. Uitenbroek DG. SISA Binomial. http: //www. quantitativeskills.com/sisa/ distributions /binomial.htm. Published 1989;Updated 1997. Accessed November 2008.